Investigation on laparoscopic sleeve gastrectomy for the management of type II diabetes mellitus

Abstract

In order to treat obesity and other disorders associated with it, laparoscopic sleeve gastrectomy (LSG) is increasingly being applied. This study examines a grading system's effectiveness in categorizing and forecasting TII-DM remission and the results of LSG aftereffects of TII-DM remission. The study included 160 TII-DM patients (80 men and 80 women) with a Body Mass Index (BMI) that is morbidly obese who had LSG between 2020 and 2023. The patient's BMI, Level of C-peptide, age, and TII-DM duration (years) comprise the ABCD score. Using this score, the absence of TII-DM following LSG was assessed Ninety treated patients had complete follow-up information at 12 months following surgery. Both the mean HbA_1c and weight loss were lowered. Significantly more patients saw progress in their blood sugar control, including nine patients who improved, 18 who experienced partial remission, and 50 who underwent complete remission. The ABCD score was greater in those with TII-DM resolution following surgery than in those without. The success rate for TII-DM remission was better for patients with higher ABCD scores (100% at score 5, which increased from 0% at point 0) LSG is a safe and efficient technique for remission of TII-DM and weight loss. The ABCD score, a straightforward multifaceted grading system, can forecast how well TII-DM will respond to LSG therapy. Surgery ObesRelat Dis: American Society for Diabetic and Weight Loss Reserved rights.